Aehr Test Systems (AEHR) - Stock Analysis

Last updated: Mar 14, 2026

TechnologyActive

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Semicap name with stacked recent orders: in Feb–early Mar 2026 announced multiple production-stage and wafer-level burn-in orders (including a $14M FOX + WaferPak order on 2026-02-26 and a follow-on silicon-photonics order on 2026-03-03). Stock ran ~55% into a 44.03 high then pulled back ~19% to 35.61 by 2026-03-06, leaving a high-volatility setup where confirmation of order-to-revenue conversion could trigger another sharp upside leg.

Loading chart data...

Idea window: 3/9/2026 – 3/16/2026Sector: Technology

AI Analyst Overview

Last Price
$35.67
Market Cap
$1.09B
1D Return
-5.26%
YTD Return
+76.67%

Loading chart data...

Valuation Metrics

P/E
-121.0
P/B
8.2
P/S
20.5
EV/EBITDA
-117.5
Div Yield
—

Fundamental Analysis

6.0

Key Financial Insights: • Strong liquidity • Declining margins • Elevated inventory Aehr has a very strong balance sheet and liquidity but worsening profitability, high operating spend and inventory vs. revenue, and an inflated market valuation not supported by earnings.

RichValuation
StrongBalance

Price Behavior

7.0

Key Price Behavior Insights: • Higher highs/lows • Pullback from peak • Support at $27–28 Support Level: $27–$28 Resistance Level: $44.03 Over last month the stock has traded in a clear uptrend—rising ~28% from $27.89 to $35.67 with higher highs/lows, but an overshoot to $44.03 then a ~19% retracement leaves elevated volatility and downside risk if $27–28 support breaks.

Bullish
Overextended

Sentiment & News

7.0

Key News Insights: • $14M order • Reinstated guidance • Elevated volatility Aehr Test Systems won multiple AI and silicon‑photonics WLBI orders (including a $14M deal), reinstated fiscal‑2026 guidance, and sparked sharp share‑price gains despite mixed analyst views.

AI
Volatility
AI

AI Summary

6.0
Neutral

AEHR has pivoted from a cyclical test‑equipment vendor into an early‑stage production‑enablement play where valuation now hinges on converting a few large hyperscaler/OSAT production wins into recurring consumables-driven revenue—if AEHR delivers several consecutive quarters of production shipments and rising consumables attach it validates the rich multiples, but missed qualifications, shipment delays, or inventory write‑downs would rapidly reverse the story.

ProductionWin
QualificationRisk
Valuation
AI summary updated today

Description

Aehr Test Systems designs and supplies test and burn-in equipment for logic, memory and optical integrated circuits, supporting both wafer-level and packaged-device verification. Its product set includes systems and handling solutions that enable full-wafer contact testing, singulated die and module burn-in, and compact single-wafer reliability checks across a range of device types and power levels. The company was incorporated in 1977 and is based in Fremont, California.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Mar 9Mar 16AEHRAehr Test Systems
Semicap name with stacked recent orders: in Feb–early Mar 2026 announced multiple production-stage and wafer-level burn-in orders (including a $14M FOX + WaferPak order on 2026-02-26 and a follow-on silicon-photonics order on 2026-03-03). Stock ran ~55% into a 44.03 high then pulled back ~19% to 35.61 by 2026-03-06, leaving a high-volatility setup where confirmation of order-to-revenue conversion could trigger another sharp upside leg.
Active-12.7%
Feb 23Mar 2AEHRAehr Test Systems
An initial production purchase order from a leading hyperscaler for multiple Sonoma systems and more than $5.5m in recent Q3 orders, tied to next‑gen AI processors, is catalyzing strong technical momentum (break around $34) and elevated investor interest, positioning AEHR for near‑term upside as those orders convert to reported revenue despite weak recent cash flow and margins.
Closed+28.3%
Dec 17Dec 24AEHRAehr Test Systems
Record Q3 revenues with strong AI/data center product demand, production capacity expansion, institutional buying, and improving gross margins underpin short-term growth, although unprofitability and technical price volatility suggest cautious optimism.
Closed+2.7%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.